EZZ
EZZ Life Science Holdings Limited
๐ฆ๐บ ASX
๐ญ LIFE SCIENCES TOOLS & SERVICES
๐ Overview
๐ Performance
๐ฐ Dividends
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
+ 135.79%
Annual Growth
4 years average annual growth
๐ฐ
1.10%
Annual dividend yield
Based on the most recent dividend
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
5
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
EZZ Life Science Holdings Ltd. is a genomic life science company, which engages in the business of formulating, producing, marketing, and selling branded health and wellbeing products to retailers and consumers domestically and internationally. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), children's health, and weight management. The firm's segments include Brought in Lines and Company Owned products. Its portfolio includes EZZ and EAORON. The EZZ-branded product range encompasses a broad selection of health and wellbeing products, catering to individuals across all age groups and owned by the Company. The EAORON-branded products comprise a range of facial care items, and the Company serves as the exclusive distributor in Australia and New Zealand for selected channels. The EZZ-branded products include EZZ Hair Growth Spray Duo, EZZ Multi Vitamins Milk Powder for Children (for children ages three plus), EZZ KidzSure Formulated Nutrition Powder (for children ages three plus) and EZZ VitalSure Formulated Nutrition Powder (for adults).
๐ Performance
Price History
+518.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ฐ Dividends
Payouts
๐ฐ Annual Dividend Yield*
1.10%
๐ฐ Annual Dividend Earnings Per $1,000 invested**
$10.97
๐ฐ Most Recent Dividend Franked Percentage Estimate
100.00%
๐ฐ Average Dividend Franked Percentage Estimate
100.00 %
๐ฐ Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of EZZ, your last dividend payment(s) would have been:
$ 89.85
on Mon Dec 09 2024
$ 200.27
on Mon Jun 17 2024
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.04
100.00%
2023
$0.02
100.00%
2022
$0.00
Infinity%
2021
$0.00
100.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
2015
$0.00
0.00%
๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$3.09
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in EZZ
5
๐ Total Capital Earnings
$13K
๐ Average investment frequency
22 weeks
๐ต Average investment amount
$2,891
โฐ Last time a customer invested in EZZ
5 days
EZZ investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
17%
50k - 100k
33%
Less than 50k
50%
๐ถ Age of investors
18 - 25
26 - 34
60%
35 - 90
40%
๐ Legal gender of investors
Female
40%
Male
60%
Pearlers who invest in EZZ also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
3.63%
๐ Share price
$102.10 AUD
๐ฆ๐บ AUSTRALIA
โณ๏ธ DIVERSIFIED
๐งฑ MATERIALS
๐ธ FINANCIALS
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
14.07%
๐ Share price
$140.20 AUD
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH
๐ GLOBAL
๐ค TECHNOLOGY
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
๐ Performance (5Yr p.a)
20.86%
๐ Share price
$63.57 AUD
๐ HIGH PRICE GROWTH
๐บ๐ธ UNITED STATES
DroneShield Ltd. engages in the development and commercialisation of hardware and software technology for drone detection and security. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-06-22. The company provides artificial intelligence-based platforms for protection against advanced threats, such as drones and autonomous systems. The company offers customers bespoke counter-drone (or counter-UAS) and electronic warfare solutions and off-the-shelf products designed to suit a variety of terrestrial, maritime, or airborne platforms. The Companyโs products include DroneGun Tactical, DroneGun MKIII, DroneSentry, DroneSentry-C2, DroneSentry-X, RfPatrol and DroneSim among others. The DroneGun Tactical is an unmanned aerial systems (UAS) countermeasure designed for two-hand operation and long-range defeat. RfPatrol is a passive/non-emitting wearable UAS detection device. The Companyโs capabilities include C-UAS, C-UxS Training, and Electronic Warfare.
๐ Performance (5Yr p.a)
29.43%
๐ Share price
$0.66 AUD
๐ HIGH PRICE GROWTH
๐ AEROSPACE & DEFENSE
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
๐ Performance (5Yr p.a)
4.12%
๐ Share price
$137.57 AUD
โณ๏ธ DIVERSIFIED
๐ธ FINANCIALS
๐ฆ๐บ AUSTRALIA
Want more shares? Try these...
F100.AX was created on 2019-07-12 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to track the price and income performance of the FTSE 100 Index (before fees and expenses). The Index provides exposure to the largest 100 comoanies traded on the London Stock Exchange, based on their market capitalisation.
๐ Performance (5Yr p.a)
2.94%
๐ Share price
$12.39 AUD
โณ๏ธ DIVERSIFIED
UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
๐ GLOBAL
Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. The company is headquartered in Adelaide, South Australia. The firm operates through three segments: AlphaRET, and Glaucoma surgical devices. The Companyโs AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser, which is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). 2RT is a patented nano-pulse laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the designing, manufacturing, marketing, and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device. The Molteno3 glaucoma drainage device platform is designed to enhance surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma.
๐ Performance (5Yr p.a)
-13.09%
๐ Share price
$0.15 AUD
๐ฉบ HEALTH CARE
Euroz Hartleys Group Ltd. engages in the business of financial solutions. The company is headquartered in Perth, Western Australia. The firm specializes in the provision of wealth management, stockbroking, corporate finance, institutional sales and targeted research services. The Companyโs segments include Private Wealth, Wholesale, Funds Management, others. The private segment includes private wealth advisers who work with high net wealth individuals, companies, SMSF and other clients. The Private wealth advisers provide investment offering of stockbroking and corporate services for clients. The Wholesale segment refers to the institutional dealing, research and corporate finance team who work with companies and other institutional clients. The Fund Management segment include Westoz Funds Management Pty Ltd, which is an investment fund whose purpose is to generate positive returns from a portfolio of stocks with a focus on the resources sector in Western Australia. The company also offers portfolio administration and reporting.
๐ Performance (5Yr p.a)
-3.32%
๐ Share price
$0.88 AUD
๐ธ FINANCIALS